top of page

BackTable / VI / Contributor

Dr. Altan Ahmed on the BackTable VI Podcast

Dr. Altan Ahmed

Interventional Radiologist

Dr. Altan Ahmed is an interventional radiologist at Moffit Cancer Center in Tampa, Florida.

Listen to Dr. Altan Ahmed on the BackTable Podcast

The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Altan Ahmed and get practical advice on how to build your practice by listening to the BackTable Podcast.

Ep 522 Advancements in Treatment of Metastatic Ocular Melanoma with Dr. Altan Ahmed and Dr. Sid Padia
00:00 / 01:04

Stay Up To Date

Follow:

Subscribe:

Sign Up:

About Dr. Altan Ahmed

Dr. Altan Ahmed, MD is an Assistant Member in the Department of Diagnostic Imaging and Interventional Radiology. Dr. Ahmed earned his MD at the University of Alabama at Birmingham and his MS in Human Genetics from Tulane University School of Medicine. He completed a Diagnostic Radiology Residency at the University of Florida, where he also served as Chief Resident. He recently completed a Vascular and Interventional Radiology Fellowship at Mayo Clinic, Jacksonville, Florida. Dr. Ahmed’s clinical interests are in Interventional oncology including radioembolization, chemoembolization, microwave ablation and cryoablation. His primary research interest is the treatment of primary and metastatic liver malignancy and optimizing the conformality of locoregional therapies.

Learn more by visiting Dr. Altan Ahmed's practice:

Podcasts Featuring Dr. Altan Ahmed

VI

VI Episode #522

Is there a way to treat liver metastasis secondary to uveal melanoma without introducing systemic, treatment-related toxicity? Dr. Altan Ahmed (interventional radiologist at Moffitt Cancer Center) and Dr. Sid Padia (interventional radiologist at UCLA) join guest-host Dr. Kavi Krishnasamy to discuss HEPZATO, a novel device-based treatment for liver metastases from uveal melanoma.

Articles Featuring Dr. Altan Ahmed

VI

The FDA-approved HEPZATO Kit offers a new liver-directed therapy for metastatic uveal melanoma. Drs. Ahmed and Padia discuss its clinical workflow, patient selection, and the evolving role of percutaneous hepatic perfusion in interventional radiology.

VI

HEPZATO is a therapeutic agent delivered via percutaneous hepatic perfusion (PHP) directly to the liver while minimizing systemic chemo-exposure. Drs. Ahmed and Padia cover how to optimize HEPZATO, including patient selection, drug dosing, and treatment cycles.

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg

Podcasts

Advancements in Treatment of Metastatic Ocular Melanoma with Dr. Altan Ahmed and Dr. Sid Padia on the BackTable VI Podcast
Multidisciplinary HCC Care: Improving the Patient Experience with Combined Clinics with Dr. Tyler Sandow, Dr. Jonathan Mizrahi, Dr. Steven Young and Deondra Bonds-Adams on the BackTable VI Podcast

Topics

Interventional Oncology (IO) Podcasts
Metastatic Ocular Melanoma Podcasts
Transarterial Chemoembolization (TACE) Podcasts

More Contributors

Dr. Venkatesh Krishnasamy on the BackTable VI Podcast

Dr. Venkatesh Krishnasamy

Dr. Siddharth Padia on the BackTable Tumor Board Podcast

Dr. Siddharth Padia

bottom of page